These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 12760377)

  • 1. Genetic engineering to study testicular tumorigenesis.
    Yan W; Burns KH; Matzuk MM
    APMIS; 2003 Jan; 111(1):174-81; discussion 182-3. PubMed ID: 12760377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclin D2 and p27 are tissue-specific regulators of tumorigenesis in inhibin alpha knockout mice.
    Burns KH; Agno JE; Sicinski P; Matzuk MM
    Mol Endocrinol; 2003 Oct; 17(10):2053-69. PubMed ID: 12855747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibin and p27 interact to regulate gonadal tumorigenesis.
    Cipriano SC; Chen L; Burns KH; Koff A; Matzuk MM
    Mol Endocrinol; 2001 Jun; 15(6):985-96. PubMed ID: 11376116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sexually dimorphic roles of steroid hormone receptor signaling in gonadal tumorigenesis.
    Burns KH; Agno JE; Chen L; Haupt B; Ogbonna SC; Korach KS; Matzuk MM
    Mol Endocrinol; 2003 Oct; 17(10):2039-52. PubMed ID: 12855748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of androgens in testicular tumor development in inhibin-deficient mice.
    Shou W; Woodruff TK; Matzuk MM
    Endocrinology; 1997 Nov; 138(11):5000-5. PubMed ID: 9348231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transgenic models to study gonadotropin function: the role of follicle-stimulating hormone in gonadal growth and tumorigenesis.
    Kumar TR; Palapattu G; Wang P; Woodruff TK; Boime I; Byrne MC; Matzuk MM
    Mol Endocrinol; 1999 Jun; 13(6):851-65. PubMed ID: 10379885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Follistatin is a modulator of gonadal tumor progression and the activin-induced wasting syndrome in inhibin-deficient mice.
    Cipriano SC; Chen L; Kumar TR; Matzuk MM
    Endocrinology; 2000 Jul; 141(7):2319-27. PubMed ID: 10875231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of cachexia-like syndrome development and reduction of tumor progression in inhibin-deficient mice following administration of a chimeric activin receptor type II-murine Fc protein.
    Li Q; Kumar R; Underwood K; O'Connor AE; Loveland KL; Seehra JS; Matzuk MM
    Mol Hum Reprod; 2007 Sep; 13(9):675-83. PubMed ID: 17704537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SMAD3 regulates gonadal tumorigenesis.
    Li Q; Graff JM; O'Connor AE; Loveland KL; Matzuk MM
    Mol Endocrinol; 2007 Oct; 21(10):2472-86. PubMed ID: 17595316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gonadotropins are essential modifier factors for gonadal tumor development in inhibin-deficient mice.
    Kumar TR; Wang Y; Matzuk MM
    Endocrinology; 1996 Oct; 137(10):4210-6. PubMed ID: 8828479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of gonadal sex cord-stromal tumor cell lines from inhibin-alpha and p53-deficient mice: the role of activin as an autocrine growth factor.
    Shikone T; Matzuk MM; Perlas E; Finegold MJ; Lewis KA; Vale W; Bradley A; Hsueh AJ
    Mol Endocrinol; 1994 Aug; 8(8):983-95. PubMed ID: 7997239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of gonadotropins inhibits gonadal tumorigenesis in mice transgenic for the mouse inhibin alpha-subunit promoter/simian virus 40 T-antigen fusion gene.
    Kananen K; Rilianawati ; Paukku T; Markkula M; Rainio EM; Huhtaniemi I
    Endocrinology; 1997 Aug; 138(8):3521-31. PubMed ID: 9231807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulable expression of inhibin A in wild-type and inhibin alpha null mice.
    Pierson TM; Wang Y; DeMayo FJ; Matzuk MM; Tsai SY; Omalley BW
    Mol Endocrinol; 2000 Jul; 14(7):1075-85. PubMed ID: 10894156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic removal of Smad3 from inhibin-null mice attenuates tumor progression by uncoupling extracellular mitogenic signals from the cell cycle machinery.
    Looyenga BD; Hammer GD
    Mol Endocrinol; 2007 Oct; 21(10):2440-57. PubMed ID: 17652186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct luteinizing hormone action triggers adrenocortical tumorigenesis in castrated mice transgenic for the murine inhibin alpha-subunit promoter/simian virus 40 T-antigen fusion gene.
    Rilianawati ; Paukku T; Kero J; Zhang FP; Rahman N; Kananen K; Huhtaniemi I
    Mol Endocrinol; 1998 Jun; 12(6):801-9. PubMed ID: 9626655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Murine Inhibin α-Subunit Haploinsufficiency Causes Transient Abnormalities in Prepubertal Testis Development Followed by Adult Testicular Decline.
    Itman C; Bielanowicz A; Goh H; Lee Q; Fulcher AJ; Moody SC; Doery JC; Martin J; Eyre S; Hedger MP; Loveland KL
    Endocrinology; 2015 Jun; 156(6):2254-68. PubMed ID: 25781564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of FSHbeta and GnRH receptor gene expression in activin receptor II knockout male mice.
    Kumar TR; Agno J; Janovick JA; Conn PM; Matzuk MM
    Mol Cell Endocrinol; 2003 Dec; 212(1-2):19-27. PubMed ID: 14654247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testicular expression of inhibin and activin subunits and follistatin in the rat and human fetus and neonate and during postnatal development in the rat.
    Majdic G; McNeilly AS; Sharpe RM; Evans LR; Groome NP; Saunders PT
    Endocrinology; 1997 May; 138(5):2136-47. PubMed ID: 9112414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term testosterone treatment prevents gonadal and adrenal tumorigenesis of mice transgenic for the mouse inhibin-alpha subunit promoter/simian virus 40 T-antigen fusion gene.
    Rilianawati ; Kero J; Paukku T; Huhtaniemi I
    J Endocrinol; 2000 Jul; 166(1):77-85. PubMed ID: 10856885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activin signaling through activin receptor type II causes the cachexia-like symptoms in inhibin-deficient mice.
    Coerver KA; Woodruff TK; Finegold MJ; Mather J; Bradley A; Matzuk MM
    Mol Endocrinol; 1996 May; 10(5):534-43. PubMed ID: 8732684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.